Mirjam Renovanz

23PUBLICATIONS
81CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Clinical neuropsychologyPredictive and prognostic markersGender studies not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 24, 2026
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort.

David Rieger, Hannes Becker, Bianca Walter

|Sep 22, 2025
Assessing the clinical benefit from medical therapies in CNS malignancies: Refining the ESMO Magnitude of Clinical Benefit Scale and the ASCO Value Framework.

Sylvia C Kurz, Mirjam Renovanz, Michael Bitzer

|Sep 10, 2025
Physician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT).

Mirjam Renovanz, Melina Hippler, Robert Kuchen

|Jul 31, 2025
Distress screening in patients with high-grade glioma: diagnostic accuracy in relation to a structured clinical interview in a multicenter cluster-randomized controlled trial.

Robert Kuchen, Susanne Singer, Melanie Schranz

|Jul 22, 2025
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation.

Florien W Boele, Sé M Frances, Amélie Darlix

|Apr 29, 2025
Sex-specific difference in treatment success/failure after vestibular schwannoma treatment.

Sophie Shih-Yüng Wang, Gerhard Horstmann, Mirjam Renovanz

Pageof 4

Frequent Collaborators

7 joint publications

Ghazaleh Tabatabai

5 joint publications

Marcos Tatagiba

4 joint publications

Jan Coburger

3 joint publications

Florian Ringel